Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
Report ID | 140892 |
Drug Identification Number | 02125323 |
Brand name | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG |
Common or Proper name | HYDROmorphone hydrochloride Controlled Release Capsules |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 3MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2021-06-15 |
Actual start date | 2021-06-15 |
Estimated end date | 2021-07-05 |
Actual end date | 2021-07-05 |
Shortage status | Resolved |
Updated date | 2021-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-06-14 | English | Compare |
v2 | 2021-06-14 | French | Compare |
v3 | 2021-06-16 | English | Compare |
v4 | 2021-06-23 | English | Compare |
v5 | 2021-06-23 | French | Compare |
v6 | 2021-06-30 | English | Compare |
v7 | 2021-06-30 | English | Compare |
v8 | 2021-06-30 | French | Compare |
v9 | 2021-06-30 | English | Compare |
v10 | 2021-06-30 | French | Compare |
v11 | 2021-07-05 | English | Compare |
v12 | 2021-07-05 | French | Compare |
v13 | 2021-07-06 | English | Compare |
Showing 1 to 13 of 13